Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN115490567B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel copper catalysis for 1,3-enynes offers high selectivity and mild conditions, significantly reducing costs for pharmaceutical intermediates manufacturing while ensuring supply chain reliability and high purity standards for global buyers.